{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:12:15Z","timestamp":1783102335791,"version":"3.54.6"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Intitute of Cancer","award":["PHRC-K13-272"],"award-info":[{"award-number":["PHRC-K13-272"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4697-7","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T08:15:31Z","timestamp":1533543331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II\/III trial \u2013 PACHA-01 (NCT02494973)"],"prefix":"10.1186","volume":"18","author":[{"given":"Diane","family":"Go\u00e9r\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Pignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximiliano","family":"Gelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9onor","family":"Benhaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Deschamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Caramella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Boige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Ducreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"de Baere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Malka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"4697_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/01.sla.0000217629.94941.cf","volume":"244","author":"S Manfredi","year":"2006","unstructured":"Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244:254\u20139.","journal-title":"Ann Surg"},{"key":"4697_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/bjs.5278","volume":"93","author":"J Leporrier","year":"2006","unstructured":"Leporrier J, Maurel J, Chiche L, et al. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg. 2006;93:465\u201374.","journal-title":"Br J Surg"},{"key":"4697_CR3","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/cncr.22448","volume":"109","author":"LC Cummings","year":"2007","unstructured":"Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007;109:718\u201326.","journal-title":"Cancer"},{"key":"4697_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/path.1711500308","volume":"150","author":"L Weiss","year":"1986","unstructured":"Weiss L, Grundmann E, Torhorst J, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol. 1986;150:195\u2013203.","journal-title":"J Pathol"},{"key":"4697_CR5","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/bjs.1800771115","volume":"77","author":"J Scheele","year":"1990","unstructured":"Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg. 1990;77:1241\u20136.","journal-title":"Br J Surg"},{"key":"4697_CR6","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/00000658-200206000-00002","volume":"235","author":"MA Choti","year":"2002","unstructured":"Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235:759\u201366.","journal-title":"Ann Surg"},{"key":"4697_CR7","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/sj.bjc.6603033","volume":"94","author":"PC Simmonds","year":"2006","unstructured":"Simmonds PC, Primrose JN, Colquitt JL, et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006;94:982\u201399.","journal-title":"Br J Cancer"},{"key":"4697_CR8","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1200\/JCO.1997.15.3.938","volume":"15","author":"Y Fong","year":"1997","unstructured":"Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol. 1997;15:938\u201346.","journal-title":"J Clin Oncol"},{"key":"4697_CR9","first-page":"1680","volume":"48","author":"Y Nakajima","year":"2001","unstructured":"Nakajima Y, Nagao M, Ko S, et al. Clinical predictors of recurrence site after hepatectomy for metastatic colorectal cancer. Hepatogastroenterology. 2001;48:1680\u20134.","journal-title":"Hepatogastroenterology"},{"key":"4697_CR10","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","volume":"371","author":"B Nordlinger","year":"2008","unstructured":"Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371:1007\u201316.","journal-title":"Lancet"},{"key":"4697_CR11","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","volume":"14","author":"B Nordlinger","year":"2013","unstructured":"Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase III trial. Lancet Oncol. 2013;14:1208\u201315.","journal-title":"Lancet Oncol"},{"key":"4697_CR12","doi-asserted-by":"publisher","first-page":"4906","DOI":"10.1200\/JCO.2008.17.3781","volume":"26","author":"E Mitry","year":"2008","unstructured":"Mitry E, Fields AL, Bleiberg H, et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol. 2008;26:4906\u201311.","journal-title":"J Clin Oncol"},{"key":"4697_CR13","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1200\/JCO.2006.06.8353","volume":"24","author":"G Portier","year":"2006","unstructured":"Portier G, Elias D, Bouche O, et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol. 2006;24:4976\u201382.","journal-title":"J Clin Oncol"},{"key":"4697_CR14","first-page":"149a","volume":"21","author":"B Langer","year":"2002","unstructured":"Langer B, Bleiberg H, Labianca R, et al. Fluorouracil (FU) plus Acide Folinique (I-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC) : Results of the ENG (EORTC\/NCIC CTG\/GIVIO) randomized trial. Proc Am Soc Clin Oncol. 2002;21:149a. (abstr 592)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"4697_CR15","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jamcollsurg.2006.12.036","volume":"204","author":"R Parks","year":"2007","unstructured":"Parks R, Gonen M, Kemeny N, et al. Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. J Am Coll Surg. 2007;204:753\u201376.","journal-title":"J Am Coll Surg"},{"key":"4697_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/00000658-198712000-00001","volume":"206","author":"AE Chang","year":"1987","unstructured":"Chang AE, Schneider PD, Sugarbaker PH, et al. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg. 1987;206:685\u201393.","journal-title":"Ann Surg"},{"key":"4697_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.7326\/0003-4819-107-4-459","volume":"107","author":"N Kemeny","year":"1987","unstructured":"Kemeny N, Daly J, Reichman B, et al. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med. 1987;107:459\u201365.","journal-title":"Ann Intern Med"},{"key":"4697_CR18","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1200\/JCO.1989.7.11.1646","volume":"7","author":"DC Hohn","year":"1989","unstructured":"Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the northern California oncology group trial. J Clin Oncol. 1989;7:1646\u201354.","journal-title":"J Clin Oncol"},{"key":"4697_CR19","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1001\/archsurg.1990.01410200086013","volume":"125","author":"JK Martin Jr","year":"1990","unstructured":"Martin JK Jr, O\u2019Connell MJ, Wieand HS, et al. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg. 1990;125:1022\u20137.","journal-title":"Arch Surg"},{"key":"4697_CR20","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1200\/JCO.1992.10.7.1112","volume":"10","author":"P Rougier","year":"1992","unstructured":"Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized control trial. J Clin Oncol. 1992;10:1112\u20138.","journal-title":"J Clin Oncol"},{"key":"4697_CR21","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(94)90750-1","volume":"344","author":"TG Allen-Mersh","year":"1994","unstructured":"Allen-Mersh TG, Earlam S, Fordy C, et al. Quality of life and survival with continuous hepatic artery floxuridine infusion for colorectal liver metastases. Lancet. 1994;344:1255\u201360.","journal-title":"Lancet"},{"key":"4697_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1200\/JCO.2000.18.2.243","volume":"18","author":"M Lorenz","year":"2000","unstructured":"Lorenz M, M\u00fcller HH. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2000;18:243\u201354.","journal-title":"J Clin Oncol"},{"key":"4697_CR23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0140-6736(03)12388-4","volume":"361","author":"DJ Kerr","year":"2003","unstructured":"Kerr DJ, McArdle CS, Ledermann J, et al. Medical research council\u2019s colorectal cancer study group; European organisation for research and treatment of cancer colorectal cancer study group. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet. 2003;361:368\u201373.","journal-title":"Lancet"},{"key":"4697_CR24","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1200\/JCO.2005.03.8166","volume":"24","author":"NE Kemeny","year":"2006","unstructured":"Kemeny NE, Niedzwiecki D, Hollis D, et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol. 2006;24:1395\u2013403.","journal-title":"J Clin Oncol"},{"key":"4697_CR25","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/jso.21753","volume":"102","author":"TP Kingham","year":"2010","unstructured":"Kingham TP, D\u2019Angelica M, Kemeny NE. Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases. J Surg Oncol. 2010;102:988\u201395.","journal-title":"J Surg Oncol"},{"key":"4697_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3816\/CCC.2005.n.027","volume":"5","author":"RJ Kelly","year":"2005","unstructured":"Kelly RJ, Kemeny NE, Leonard GD. Current strategies using hepatic arterial infusion chemotherapy for the treatment of colorectal cancer. Clin Colorectal Cancer. 2005;5:166\u201374.","journal-title":"Clin Colorectal Cancer"},{"key":"4697_CR27","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1200\/JCO.2005.07.100","volume":"23","author":"N Kemeny","year":"2005","unstructured":"Kemeny N, Jarnagin W, Paty P, et al. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol. 2005;23:4888\u201396.","journal-title":"J Clin Oncol"},{"key":"4697_CR28","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/annonc\/mdm405","volume":"18","author":"DJ Gallagher","year":"2007","unstructured":"Gallagher DJ, Capanu M, Raggio G, Kemeny N. Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis. Ann Oncol. 2007;18:1995\u20139.","journal-title":"Ann Oncol"},{"key":"4697_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/01.cad.0000131684.06390.fe","volume":"15","author":"R Dzodic","year":"2004","unstructured":"Dzodic R, Gomez-Abuin G, Rougier P, et al. Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model. Anticancer Drug Des. 2004;15:647\u201350.","journal-title":"Anticancer Drug Des"},{"key":"4697_CR30","first-page":"5203","volume":"23","author":"I Guthoff","year":"2003","unstructured":"Guthoff I, Lotspeich E, Fester C, et al. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility. Anticancer Res. 2003;23:5203\u20138.","journal-title":"Anticancer Res"},{"key":"4697_CR31","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1200\/JCO.2005.05.120","volume":"23","author":"M Ducreux","year":"2005","unstructured":"Ducreux M, Ychou M, Laplanche A, et al. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol. 2005;23:4881\u20137.","journal-title":"J Clin Oncol"},{"key":"4697_CR32","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/SLA.0b013e3181d35983","volume":"251","author":"D Go\u00e9r\u00e9","year":"2010","unstructured":"Go\u00e9r\u00e9 D, Deshaies I, de Baere T, et al. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases. Ann Surg. 2010;251:686\u201391.","journal-title":"Ann Surg"},{"key":"4697_CR33","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1200\/JCO.1990.8.11.1885","volume":"8","author":"LD Wagman","year":"1990","unstructured":"Wagman LD, Kemeny MM, Leong L, et al. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol. 1990;8:1885\u201393.","journal-title":"J Clin Oncol"},{"key":"4697_CR34","first-page":"155","volume":"42","author":"NJ Lygidakis","year":"1995","unstructured":"Lygidakis NJ, Ziras N, Parissis J. Resection versus resection combined with adjuvant pre- and post-operative chemotherapy\u2013immunotherapy for metastatic colorectal livercancer. A new look at an old problem. Hepatogastroenterology. 1995;42:155\u201361.","journal-title":"Hepatogastroenterology"},{"key":"4697_CR35","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/00000658-199812000-00006","volume":"228","author":"M Lorenz","year":"1998","unstructured":"Lorenz M, Muller HH, Schramm H, et al. Randomized trial of surgery vs. surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German cooperative on liver metastases (Arbeitsgruppe Lebermetastasen). Ann Surg. 1998;228:756\u201362.","journal-title":"Ann Surg"},{"key":"4697_CR36","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1056\/NEJM199912303412702","volume":"341","author":"N Kemeny","year":"1999","unstructured":"Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med. 1999;341:2039\u201348.","journal-title":"N Engl J Med"},{"key":"4697_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s004230050199","volume":"384","author":"C Rudroff","year":"1999","unstructured":"Rudroff C, Altendorf-Hoffmann A, Stangl R, et al. Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases. Langenbeck\u2019s Arch Surg. 1999;384:243\u20139.","journal-title":"Langenbeck\u2019s Arch Surg"},{"key":"4697_CR38","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1549::AID-CNCR8>3.0.CO;2-K","volume":"88","author":"T Tono","year":"2000","unstructured":"Tono T, Hasuike Y, Ohzato H, et al. Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: a randomized study. Cancer. 2000;88:1549\u201356.","journal-title":"Cancer"},{"key":"4697_CR39","first-page":"1685","volume":"48","author":"NJ Lygidakis","year":"2001","unstructured":"Lygidakis NJ, Sgourakis G, Vlachos L, et al. Metastatic liver disease of colorectal origin: the value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study. Hepatogastroenterology. 2001;48:1685\u201391.","journal-title":"Hepatogastroenterology"},{"key":"4697_CR40","first-page":"1499","volume":"20","author":"MM Kemeny","year":"2002","unstructured":"Kemeny MM, Adak S, Gray B, et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy\u2014an intergroup study. J Clin Oncol. 2002;20:1499\u2013505.","journal-title":"J Clin Oncol"},{"key":"4697_CR41","first-page":"CD003770","volume":"4","author":"R Nelson","year":"2006","unstructured":"Nelson R, Freels S. Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver. Cochrane Database Syst Rev. 2006;4:CD003770.","journal-title":"Cochrane Database Syst Rev"},{"key":"4697_CR42","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1056\/NEJM200502173520723","volume":"352","author":"NE Kemeny","year":"2005","unstructured":"Kemeny NE, Gonen M. Hepatic arterial infusion after liver resection. N Engl J Med. 2005;352:734\u20135.","journal-title":"N Engl J Med"},{"key":"4697_CR43","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/SLA.0b013e31822f4f88","volume":"254","author":"MG House","year":"2011","unstructured":"House MG, Kemeny NE, G\u00f6nen M, et al. Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer. Ann Surg. 2011;254:851\u20136.","journal-title":"Ann Surg"},{"key":"4697_CR44","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1200\/JCO.2009.24.6728","volume":"28","author":"SR Alberts","year":"2010","unstructured":"Alberts SR, Roh MS, Mahoney MR, et al. Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a north central Cancer treatment group (NCCTG)\/ National Surgical Adjuvant Breast and bowel project (NSABP) phase II intergroup trial, N9945\/CI-66. J Clin Oncol. 2010;28:853\u20138.","journal-title":"J Clin Oncol"},{"key":"4697_CR45","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I","volume":"77","author":"B Nordlinger","year":"1996","unstructured":"Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Fran\u00e7aise de Chirurgie. Cancer. 1996;77:1254\u201362.","journal-title":"Cancer"},{"key":"4697_CR46","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","volume":"230","author":"Y Fong","year":"1999","unstructured":"Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309\u201318.","journal-title":"Ann Surg"},{"key":"4697_CR47","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1072-7515(99)00089-7","volume":"189","author":"S Iwatsuki","year":"1999","unstructured":"Iwatsuki S, Dvorchik I, Madariaga JR, et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 1999;189:291\u20139.","journal-title":"J Am Coll Surg"},{"key":"4697_CR48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/SLA.0b013e3180603039","volume":"246","author":"S Zakaria","year":"2007","unstructured":"Zakaria S, Donohue JH, Que FG, et al. Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg. 2007;246:183\u201391.","journal-title":"Ann Surg"},{"key":"4697_CR49","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/SLA.0b013e318142d964","volume":"246","author":"HZ Malik","year":"2007","unstructured":"Malik HZ, Prasad KR, Halazun KJ, et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg. 2007;246:806\u201314.","journal-title":"Ann Surg"},{"key":"4697_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/SLA.0b013e31815aa2c2","volume":"247","author":"M Rees","year":"2008","unstructured":"Rees M, Tekkis PP, Welsh FK, O\u2019Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247:125\u201335.","journal-title":"Ann Surg"},{"key":"4697_CR51","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/SLA.0b013e31827b9005","volume":"257","author":"D Go\u00e9r\u00e9","year":"2013","unstructured":"Go\u00e9r\u00e9 D, Benhaim L, Bonnet S, et al. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy. Ann Surg. 2013;257:114\u201320.","journal-title":"Ann Surg"},{"key":"4697_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","volume":"10","author":"R Simon","year":"1989","unstructured":"Simon R. Optimal two-stage designs for phase II clinical trials in oncology. Control Clin Trials. 1989;10:1\u201310.","journal-title":"Control Clin Trials"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4697-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4697-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4697-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T19:11:39Z","timestamp":1565032299000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4697-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4697"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4697-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]},"assertion":[{"value":"7 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has received the ethical approval of the Comit\u00e9 de Protection des Personnes \u2013 Ile de France V. N\u00b0 EudraCT: 2014\u2013005110-32 (Date of approval May 5, 2017). Informed consent signed by the patient or his\/her legal representative will be obtained from the participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study does not contain individual data of person.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"787"}}